Transgenic pig models of cystic fibrosis
This invention relates to transgenic pig models of cystic fibrosis, cells that can be used to make such animals, and methods of making and using these pigs and cells.
1. A transgenic pig comprising a genome wherein:
(i) (a) both of the pig CFTR alleles have been knocked out, or (b) both of the pig CFTR alleles have been replaced with a mutant porcine or human CFTR gene comprising a deletion of F508; and
(ii) the genome comprises a wildtype CFTR transgene under the control of an intestinal cell-specific promoter resulting in wildtype CFTR expression in intestinal cells of the pig;
wherein said pig exhibits reduced meconium ileus relative to a pig lacking expression of said CFTR transgene in intestinal cells.
2. The transgenic pig of claim 1 , wherein said intestinal cell-specific promoter is an intestinal fatty acid binding protein (iFABP) promoter.
3. The transgenic pig of claim 1 , wherein both of the pig CFTR alleles of the genome of said pig have been knocked out.
4. The transgenic pig of claim 1 , wherein both of the pig CFTR alleles of the genome of said pig have been replaced with a mutant porcine or human CFTR gene comprising a deletion of F508.
5. The transgenic pig of claim 4 , wherein said mutant CFTR gene comprising a deletion of F508 is a human CFTR gene.
6. The transgenic pig of claim 4 , wherein said mutant CFTR gene comprising a deletion of F508 is a porcine CFTR gene.
7. The transgenic pig of claim 1 , wherein the pig has one or more phenotypes selected from the group consisting of (a) an electrophysiological phenotype similar to that of human cystic fibrosis, (b) pancreatic insufficiency or abnormalities, (c) hepatic abnormalities, (d) gall bladder and/or bile duct abnormalities, (e) tracheal abnormalities, (f) cystic fibrosis lung disease, (g) sweat gland abnormalities, and (h) kidney abnormalities.
8. An isolated cell or tissue of a pig of claim 1 .
9. A transgenic pig comprising a genome wherein:
(i) (a) one of the pig CFTR alleles has been knocked out, or (b) one of the pig CFTR alleles has been replaced with a mutant porcine or human CFTR gene comprising a deletion of F508; and
(ii) the genome comprises a wildtype CFTR transgene under the control of an intestinal cell-specific promoter resulting in wildtype CFTR expression in intestinal cells of the pig;
wherein said pig, when bred with another pig having the features of (i) and (ii), contributes to the generation of off-spring that (c) comprise a genome wherein both of the pig CFTR alleles have been knocked out, or both of the pig CFTR alleles have been replaced with a mutant porcine or human CFTR gene comprising a deletion of F508, (d) comprise a genome that comprises a CFTR transgene under the control of an intestinal cell-specific promoter, and (e) has reduced meconium ileus relative to a pig lacking expression of said CFTR transgene in intestinal cells.
10. An isolated cell or tissue of the transgenic pig of claim 9 .
11. The transgenic pig of claim 9 , wherein one of the pig CFTR alleles of the genome of said pig has been knocked out.
12. The transgenic pig of claim 9 , wherein one of the pig CFTR alleles of the genome of said pig have been replaced with a mutant porcine or human CFTR gene comprising a deletion of F508.
13. The transgenic pig of claim 12 , wherein said mutant CFTR gene comprising a deletion of F508 is a human CFTR gene.
14. The transgenic pig of claim 12 , wherein said mutant CFTR gene comprising a deletion of F508 is a porcine CFTR gene.
15. The transgenic pig of claim 9 , wherein said intestinal cell-specific promoter is an intestinal fatty acid binding protein (iFABP) promoter.
16. The transgenic pig of claim 1 , wherein the pig exhibits one or more characteristics of cystic fibrosis in their lungs.
17. The transgenic pig of claim 1 , wherein said pig does not require surgical correction of meconium ileus within 24-36 hours after birth in order to survive.
18. The transgenic pig of claim 9 , wherein said off-spring further (f) do not require surgical correction of meconium ileus within 24-36 hours after birth in order to survive.